Iron chelation increases the tolerance of Escherichia coli to hyper-replication stress

Scientific Reports
Godefroid CharbonAnders Løbner-Olesen

Abstract

In Escherichia coli, an increase in the frequency of chromosome replication is lethal. In order to identify compounds that affect chromosome replication, we screened for molecules capable of restoring the viability of hyper-replicating cells. We made use of two E. coli strains that over-initiate DNA replication by keeping the DnaA initiator protein in its active ATP bound state. While viable under anaerobic growth or when grown on poor media, these strains become inviable when grown in rich media. Extracts from actinomycetes strains were screened, leading to the identification of deferoxamine (DFO) as the active compound in one of them. We show that DFO does not affect chromosomal replication initiation and suggest that it was identified due to its ability to chelate cellular iron. This limits the formation of reactive oxygen species, reduce oxidative DNA damage and promote processivity of DNA replication. We argue that the benzazepine derivate (±)-6-Chloro-PB hydrobromide acts in a similar manner.

References

Jun 1, 1978·Molecular & General Genetics : MGG·G Kellenberger-GujerL Caro
Feb 14, 1968·Journal of Molecular Biology·S Cooper, C E Helmstetter
Jan 1, 1981·Cold Spring Harbor Symposia on Quantitative Biology·M S GuyerK B Low
Jan 1, 1993·Psychopharmacology·M R WeedW L Woolverton
Nov 26, 1999·Biochimie·W MesserJ Zakrzewska-Czerwinska
Nov 18, 2000·The EMBO Journal·U von FreieslebenA Løbner-Olesen
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kenneth N RaymondSanggoo S Kim
Jul 15, 2004·Dalton Transactions : an International Journal of Inorganic Chemistry·Mary J Sever, Jonathan J Wilker
Dec 17, 2004·Journal of the American Chemical Society·Francisco Barona-GómezGregory L Challis
Jun 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sunny ParkJames A Imlay
Jul 11, 2006·Nature Structural & Molecular Biology·Jan P ErzbergerJames M Berger
Mar 4, 2008·FEMS Microbiology Letters·Solveig FossumKirsten Skarstad
Mar 17, 2010·The Journal of Antimicrobial Chemotherapy·Line JohnsenKirsten Skarstad
Apr 9, 2010·Natural Product Reports·Robert C Hider, Xiaole Kong
Feb 9, 2011·Molecular Microbiology·Godefroid CharbonAnders Løbner-Olesen
Aug 2, 2012·Antimicrobial Agents and Chemotherapy·Mitchell G ThompsonDaniel V Zurawski
Jan 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kazutoshi Kasho, Tsutomu Katayama
Mar 9, 2013·Cold Spring Harbor Perspectives in Biology·Kirsten Skarstad, Tsutomu Katayama
Sep 12, 2013·PloS One·Susanne KjelstrupAnders Løbner-Olesen
Nov 13, 2014·Nucleic Acids Research·Godefroid CharbonAnders Løbner-Olesen
Jun 18, 2015·Frontiers in Microbiology·Alan C Leonard, Julia E Grimwade
Jul 26, 2016·Frontiers in Molecular Biosciences·Leise RiberAnders Løbner-Olesen
Jan 28, 2017·PLoS Genetics·Godefroid CharbonAnders Løbner-Olesen

❮ Previous
Next ❯

Citations

Nov 25, 2018·Genes·Belén Mendoza-ChamizoGodefroid Charbon

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

Xcalibur
Adobe Illustrator
ImageJ
Apogee

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.